Hetal H. Mehta, MD, FACC, FSCAI

Interventional/Structural Cardiologist @DoylestownHlth, former @yalecardiology structural fellow, @hopkinsheart IC fellow, @TJheartfellows. Tweets are my own.

[Hetal H. Mehta, MD, FACC, FSCAI @DocMehta407]

Our 1000th TAVR! So proud of our amazing team!! @DoylestownHlth

[Gregg W. Stone MD @GreggWStone]

Complete revasc (CR) in pts with non-shock STEMI and multivessel ds. reduces MACE. But is the best timing for non-culprit lsn PCI immediate (during primary PCI) or staged? Our new meta-analysis publ in Circ CV Interv suggests immediate CR may increase mortality, same as in shock.

[SCAI @SCAI]

Congratulations to the #SCAI2026 30 in Their 30s recipients—highlighting the next generation of leaders advancing interventional cardiology through clinical excellence, research, and mentorship. 🌟👩‍⚕️👨‍⚕️

Learn more ➡️ https://t.co/gU45X8OmDl

@Dr_AbuDaya @ZaidAlMarzooq @Obadah1Md @nyalborgesmd @BhattadMD @YChowdhuryMD @DocEBROhimi @fangjonathanx @HarmanSGill @KIgbalode @AhmadJabri8 @vikjag45 @ikutkutMD @NinoNJ @MukarramOsama @DrPrimeroNg @BhavanPentaMD @haseebqazi @frahman480 @sumonroy_md @drsharmatoishi @Tabaza @BWanamakerMD @ATYounesMD @JDawnAbbott1 @CCAD_MHIF @MHIF_Heart

[Hetal H. Mehta, MD, FACC, FSCAI @DocMehta407]

Thrilled to welcome the Pascal platform to our structural heart program @DoylestownHlth @PennMedicine Expanding our toolkit means more options, more precision & more patients getting the care they deserve. Proud of the excellent outcomes we continue to achieve with every M-TEER🫀

[EuroIntervention @EuroInterventio]

After TAVI, invasively measured transvalvular gradients—but not echocardiography-derived gradients— were associated with mortality up to 2 years. Echocardiography systematically overestimated gradients, particularly with balloon-expandable valves. Read more in our #EIJBestOf 👇
#CardioTwitter #TAVI

🔗https://t.co/Nb5dAvZLpB

@RikAdrMD @verhemel @Rjnuis @JoostDaemen @drnvanmieghem

[Hetal H. Mehta, MD, FACC, FSCAI @DocMehta407]

Hospital-level variability in NSTEMI management and outcomes @CRT_meeting #CRT2026

[EuroIntervention @EuroInterventio]

New State-of-the-Art: lesion stratification with intracoronary imaging, from morphology-guided PCI to AI-enabled morphofunctional assessment, outlining the next paradigm shift in interventional cardiology.
#InterventionalCardiology #IntracoronaryImaging

https://t.co/Bc6jp82gE1

@m_g_mcgarvey @K_DeSilva @DrKeeble @DrPeterOKane @ziadalinyc @divaka_perera @DrJMHill
@DrNileshPareek

[JACC Journals @JACCJournals]

LAA closure – is peri-device patency a problem to address? This pooled meta-analysis reveals that residual LAA patency detected by cardiac CT post-#LAAO significantly raises thromboembolic risk. https://t.co/6nIr7ozEXl

#JACCIMG @KasperKorsholm @XanderJacquemyn @IbrahimSultanMD

[JACC Journals @JACCJournals]

#DAPT after valve-in-valve #TAVR may be associated with a lower 1-yr incidence of stroke. In contrast, no significant difference was observed for other major ischemic and bleeding outcomes or for premature valve deterioration. https://t.co/2QUhtuN2H8 #JACCINT @saia_francesco

[Dr. Faisal Rahman @frahman480]

@NEJM Impressive #AI #infographic that can be generated with a reasonable prompt, and easily improved to incl other details e.g. exclusions no left main, no bifurcation in #TARGETFIRST https://t.co/qVmuAjhBPD

[Dr. Faisal Rahman @frahman480]

Often get my new fellows thinking PCWP 15 is a hard and fast. For anyone who haven't read @Brian_Houston12 @RyanTedfordMD https://t.co/29QX5DL8iS - highly recommend

[Dr. Faisal Rahman @frahman480]

An analysis of mAFP in #MI #cardiogenicshock including time related analysis. Of course, observational but highlights how we are using #MCS currently & understanding #DangerShock approach to treatment #PatientSafety #outcomes https://t.co/hq8DiiRAQz @sciencedirect @hopkinsheart

[JACC Journals @JACCJournals]

New #JACCAdvances review offers a comprehensive analysis integrating device geometry, sinus flow dynamics, and native tissue activity to inform personalized, time-limited anticoagulation strategies in high-risk patients https://t.co/jcjARVFMrc #TAVR

[Dr. Faisal Rahman @frahman480]

NOTION-2 continues to show a major consideration of PPM in #SAVR vs #TAVR. Something to consider in "borderline" cases & particularly small annuli. #TAVR maybe getting better w/ bicuspid but numerically at least significant outcome difference to consider https://t.co/zjETfKcSdI

[CircInterventions @CircIntv]

Do female patients respond differently than males? Higher 2-year MACE after sirolimus-coated balloon angioplasty for female patients with in-stent restenosis. A hypothesis generating research letter @Dr.LucaTesta @leoneppmd @AGrecoMD @Dari08s
https://t.co/oSMRqCSJo1

[JACC Journals @JACCJournals]

#AorticValve calcification isn't just aging—it's a complex disease! #JACCAsia review dives into new research on inflammation, lipid deposits & fibrosis, plus promising therapies like lipid-lowering drugs & next-gen valve designs. A step toward better care! https://t.co/dplwrF26jR

[C. Michael Gibson MD @CMichaelGibson]

Late-breaker at #ACC2025: Dr. Joo-Yong Hahn presented the SMART-CHOICE 3 trial, showing superior efficacy and comparable safety of clopidogrel as long-term maintenance monotherapy in high-risk pts compared to aspirin. Slides here: https://t.co/XLZy7c4e6j

[Circulation @CircAHA]

#ACC25 #CircSimPub Two-year follow-up results of TRILUMINATE trial indicate significant reduction in tricuspid regurgitation severity & decreased HF hospitalization rates with tricuspid TEER compared to medical therapy. https://t.co/H9ef9xgLtt #AHAJournals @hahn_rt @tavrkapadia

[JACC Journals @JACCJournals]

In a late-breaking clinical trial, Drs. @johnkforrest, @MReardon19, et al report that low-risk patients with AS treated with #TAVR had similar rates of mortality and #stroke at 5 years compared to those treated with surgery https://t.co/qdOAoWLF1k

#JACC #ACC25 #vhdAS #SAVR

[CircInterventions @CircIntv]

Maintaining radial patency after CABG Surgery: the Randomized ASRAB -Pilot Study. Lower graft failure with nicorandil or isosorbide mononitrate compared to diltiazem #AHAJournals https://t.co/vu1gwtwZID

[JACC Journals @JACCJournals]

In patients with #AFib and stable #cvCAD, OAC monotherapy, compared with OAC plus SAPT, was not associated with a statistically significant increased risk of ischemic events but resulted in a significantly reduced risk of bleeding. https://t.co/vOen1sLSZX

#JACC #cvCoag @bbikdeli